VF
ATHE

Virtu Financial’s Alterity Therapeutics ATHE Stock Holding History

Virtu Financial’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,799
Closed -$27K – 1397
2023
Q4 		$27K Buy
+10,799
New +$26.7K ﹤0.01% 1270
2022
Q2 		– Sell
-1,959
Closed -$16K – 1570
2022
Q1 		$16K Buy
+1,959
New +$16.3K ﹤0.01% 1320
2021
Q4 		– Sell
-1,135
Closed -$14K – 1695
2021
Q3 		$14K Buy
+1,135
New +$15.8K ﹤0.01% 1401
2021
Q2 		– Sell
-6,991
Closed -$101K – 1496
2021
Q1 		$101K Buy
+6,991
New +$118K 0.01% 1322
2018
Q1 		– Sell
-2,113
Closed -$66K – 1934
2017
Q4 		$66K Buy
+2,113
New +$66.3K ﹤0.01% 2018

Other funds holding ATHE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
TLCM
Twin Lakes Capital Management Redwood Shores, California $220M AUM 31.75% 1-Year Est. Return
PCA
Providence Capital Advisors Charlotte, North Carolina $613M AUM 17.83% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SWM
Sugarloaf Wealth Management Duluth, Georgia $529M AUM 14.14% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Virtu Financial's ATHE Position: Q1 2024 in Review

Virtu Financial sold out of Alterity Therapeutics (ATHE) in Q1 2024, closing a stake of 10,799 shares — an estimated $27K sold.

Virtu Financial first reported a position in ATHE in Q4 2017 and held it in 5 quarters. The position peaked at $101K in Q1 2021. 10 funds tracked by Wall St. Rank hold ATHE as of Q1 2024.

  • Virtu Financial reported no remaining Alterity Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Virtu Financial sold 10,799 Alterity Therapeutics shares in Q1 2024, an estimated $27K.
  • Virtu Financial first reported a position in Alterity Therapeutics in Q4 2017 and held it in 5 quarters.
  • Virtu Financial's Alterity Therapeutics position peaked at $101K in Q1 2021.
  • 10 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q1 2024.

Based on Virtu Financial's 13F filing for Q1 2024, filed 20 May 2024.